does semaglutide make you vomit Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss 20 Ozempic and Wegovy Side

Exenatide (EXE) (2 mg weekly), Dapagliflozin (DAPA) (10 mg daily), Exenatide + Dapagliflozin (2 mg weekly/10 mg daily), Dapagliflozin (10 mg) + Metformin (MET) (2000 mg extended release daily), or Phentermine (7.5 mg)/Topiramate were given to the patients for 24 weeks (46 mg extended release daily)

Weight and anthropometric outcomes Percentage weight loss The average percentage weight-loss trajectories with semaglutide and placebo over 4 years of observation are shown in Fig

Cysts : Large, pus-filled lumps under the skin, often painful and prone to scarring

Wegovy is FDA-approved for weight loss, while Ozempic was originally approved for diabetes management